What Is Microdosing GLP-1 Medications?

Microdosing GLP-1 medications means starting at significantly lower doses than standard guidelines recommend. In some cases, this may be as low as 0.05–0.1 mg of semaglutide per week, compared to the usual starting dose of 0.25 mg.

The goal of microdosing is simple:
to allow the body to adapt slowly and gently—minimizing side effects like nausea, fatigue, or gastrointestinal distress—while still gaining the benefits of appetite regulation, improved insulin sensitivity, reduced inflammation, and overall metabolic rebalancing.

What’s Important to Know First

It’s important to be transparent: microdosing compounded GLP-1 weight-loss medications has not been studied in large randomized, controlled, double-blind trials.

Because these medications are used at much smaller doses, the side-effect profile is likely lower than the full-dose protocols that have been studied. However, at this time, the evidence supporting microdosing is anecdotal and based on clinical experience, not proven science.

That said, many patients simply cannot tolerate standard dosing—and microdosing offers an alternative that may allow them to benefit from GLP-1 therapy without feeling overwhelmed.

About Compounded GLP-1 Medications

Compounded GLP-1 medications are often combined with vitamins such as B12, B6, and sometimes chromium, which may help support energy levels and metabolic health.

These compounded formulations are altered from the original patented medication, which is why they can be offered through compounding pharmacies.

In my experience, these formulations are safe when dosed and handled properly. They must be:

• Refrigerated at all times

• Discarded after 28 days once the vial has been punctured

Proper storage and handling are essential.

Why Microdose?

Many patients are surprised to learn that more is not always better. Microdosing offers several distinct advantages.

1. Fewer Side Effects

A common reason people stop GLP-1 medications early is nausea, reflux, constipation, or fatigue. Starting at a microdose allows the body to adjust gradually, often eliminating the need for aggressive symptom management.

2. Smoother Appetite Regulation

Microdosing avoids the intense appetite suppression or early food aversion that some patients experience. Instead, it supports natural satiety and mindful eating—making it easier to build sustainable habits rather than relying solely on the medication.

3. Metabolic Health Comes First

At low doses, GLP-1s can help stabilize blood sugar and improve insulin resistance before significant weight loss occurs. This is particularly powerful for women with PCOS, perimenopausal weight gain, or metabolic sluggishness, where hormone and blood sugar balance are key.

4. Hormone-Sensitive Support

Women in hormonal transitions—perimenopause, menopause, PCOS, postpartum—often need a more nuanced approach. Microdosing may help stabilize metabolic and mood shifts without triggering overwhelming physical changes too quickly.

Who Is Microdosing Best For?

Microdosing may be a good option for:

• Women with PCOS, perimenopause, menopause, or insulin resistance

• Patients with GI sensitivity or a history of medication intolerance

• Individuals seeking metabolic or hormonal balance without rapid weight loss

• Patients who want to layer GLP-1 therapy with lifestyle changes

• Those looking for anti-inflammatory effects that have been anecdotally reported, such as reduced brain fog or pain

Is Microdosing Less Effective?

Not at all.

For many patients, microdosing is actually more effective—because it allows them to stay on the medication longer, build foundational health habits, and avoid the cycle of starting and stopping due to side effects.

The body responds to consistency, not intensity.
Microdosing honors that principle.

Adjusting the Dose Over Time

Microdosing does not mean staying at a low dose forever.

This slow titration—gradually increasing the dose—reduces the risk of unpleasant side effects and gives us more control. Along the way, we can monitor labs, hormonal markers, and clinical symptoms to ensure we are optimizing, not overwhelming, the body.

If beneficial effects aren’t seen at a microdose, the dosage can be increased to the standard starting dose of semaglutide or tirzepatide, thoughtfully and intentionally.

What About Liraglutide?

While GLP-1 medications have received a lot of attention in recent years, there are older GLP-1 options that are still very useful.

Liraglutide is available through compounding pharmacies and is administered as a daily injection.

Why inject daily instead of weekly?

Some patients don’t tolerate long-acting, once-weekly medications well. These extended-release formulations stay in the body for a long time. Semaglutide and tirzepatide have a half-life of 5–7 days, meaning it can take weeks for the medication to fully leave your system.

Liraglutide, on the other hand, has a half-life of about 15 hours—meaning half the medication is gone from the body in that time. This allows for more flexibility and quicker resolution of side effects if they occur.

This difference is also why GLP-1 medications must be stopped at least one week before procedures such as colonoscopies.

There are pros and cons to every medication. Understanding how they work in the body gives you the information needed to make informed choices.

Final Thoughts

GLP-1 medications are powerful.
But power doesn’t need to mean overwhelming the body.

Microdosing allows us to leverage the benefits—insulin regulation, appetite reset, and inflammation reduction—without shocking the system. This approach aligns with my philosophy of medicine: root-cause healing, gentle rebalancing, and supporting the body’s ability to restore itself.

Book a free 15-minute consultation if you’d like to start the conversation.
No pressure. No commitment. Just clarity.

There is another way.
And sometimes, it starts small.